孙逊，女，四川大学华西药学院药剂学博士，美国宾夕法尼亚大学医学院博士后。现任四川大学华西药学院教授，博士生导师，国家优秀青年科学基金获得者，教育部新世纪优秀人才，四川省高级留学回国人员，四川省药学会副秘书长，四川省学术和技术带头人后备人选，兼任英国中央兰开夏大学访问研究员（Visiting Fellow）。研究方向为分子药剂学与药物靶向传递系统。
1991～1996 华西医科大学药学院 获理学学士学位1996～2000 广州珠江医院 从事临床药学工作2000～2005 四川大学华西药学院 获药剂学博士学位2005～ 四川大学华西药学院任讲师、副教授2005～2007 美国宾夕法尼亚大学医学院博士后, 师从世界著名基因治疗学家James Wilson教授2007～2008 美国密西根大学药学院博士后, 师从Kyung Dull Lee 教授。1. 基于载体构-效关系设计的多功能高效肺靶向siRNA传递系统研究(国家自然科学基金，项目编号：309。73657，起止日期2010.1-2012.12, 负责人)2. Hyaluronan-based injectable material for tissue engineering（欧盟第七框架项目，项目编号：PIRSES-GA-2008-230791,起止日期2010.1-2012.12, 负责人)3. 呼吸道粘膜上皮细胞靶向基因传递系统研究 (国家自然科学基金，项目编号：3060。0786，起止日期2007.1-2009.12, 负责人)4. 马来酸氟吡啶缓释片、缓释胶囊的研制（企业合作项目，项目编号：09H0114-2,负责人）5. IL-12基因纳米脂质体注射剂的研究 (四川省重点科技攻关项目，项目编号：05SG022-019-2,起止日期2006.1-2008.12, 负责人)6. 靶向释药系统与新制剂技术平台的建设（国家科技重大专项项目，项目编号：2009ZX09310-002,主研）7. 药物及治疗基因纳米粒制剂的研究与开发（国家高技术研究发展863计划课题，项目编号：2003AA217010,主研）8. 血管内注射药用高分子材料PELGE及其肝靶向纳米粒研制（国家自然科学基金重点项目，项目编号：3043。0770,主研）1.“治疗基因靶向传递系统的研究”2006年四川省科技进步三等奖 （第2完成人）2. 2008年度“全国百篇优秀博士论文”提名奖3. 2009年第四届国际药物制剂论坛优秀青年报告奖4. 2005年和2009年分别获得日本永井基金会Travel Grant1. Xun Sun, Chet Provoda, Kyung-Dall Lee. Enhanced in vivo gene expression mediated by Listeriolysin O incorporated anionic LPDII: Its utility in Cytotoxic T lymphocyte-inducing DNA Vaccine. Journal of Controlled Release. IF=5.949， 2010；148（2）：219-225.2. Xun Sun, You Lu, Larry Bish, Roberto Calcedo, James M. Wilson, Guangping Gao*. Molecular analysis of vector genome strucures following liver transduction by conventional and self-complementary AAV serotype vectors in murine and nonhuman primate models. Human Gene Therapy. IF=4.202. 2010;21(6)1-12.3. Jianfeng Han, Dong Zhao, Zhirong Zhong, , Zhirong Zhang, Tao Gong and Xun Sun*. Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction. Nanotechnology, IF=3.137. 2010;21(10):105106.4. Zhi-Rong ZHONG, San-Jun SHI, Jian-Feng HAN, Zhi-Rong ZHANG, Xun SUN*. Anionic Liposomes Increase the Efficiency of Adenovirus-mediated Gene Transfer to Coxsackie-Adenovirus Receptor Deficient Cells, Mol. Pharm. 2010;7(1)105-115. IF=5.408.5. Jiao Lu, Di Zhu, Zhi-rong Zhang, Li Hai, Yong Wu, Xun Sun*. Novel synthetic LPDs consisting of different cholesterol derivatives for gene transfer into hepatocytes. Journal of Drug Targeting. 2010 Aug;18(7):520-35. IF=2.885.6. Lili He, Likai Yang, Zhi-rong Zhang, Tao Gong, Li Deng, Zhongwei Gu, Xun Sun*. In vitro evaluation of the genotoxicity of a family of novel MeO-PEG-poly (D,L- lactic-co-glycolic acid)-PEG-OMe Triblock Copolymer nanoparticles. Nanotechnology, IF=3.137. 2009;20(45):455102.7. Qing-Hua Zhou, Xun Sun, Lin-Yuan Zeng, Jie Liu, Zhi-Rong Zhang*, A Randomized Multi- center Phase II Clinical trial of Mitoxantrone- loaded Polybutylcyanacrylate nanoparticles in the Treatment of 108 patients with inoperable hepatocellular carcinoma. Nanomedicines-UK, 2009：5（4）419-423. IF=5.44（共同第一作者）.8. Xun SUN，Hong-Wei ZHANG，Zhi-Rong ZHANG. Growth Inhibition of the Pulmonary Metastatic Tumors by Systemic Delivery of p27kip1 Gene Using Lyophilized Lipid-Polycation-DNA complexes (LPD). Journal of Gene Medicine, 2009;11:535-544. IF=3.141.9. Zhi-xiang Yuan, Xun Sun*, Tao Gong, Hong Ding, Fu Chen, Zhi-rong Zhang*. Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier. Journal of Drug Targeting.2007,15(4):269-278. SCI.10. Guang-Ping Gao, You Lu, Xun Sun, Julie Johnston, Roberto Calcedo, Rebecca Grant and James M. Wilson. High level transgene expression in nonhuman primate liver with novel AAV serotypes containing self-complementary genomes. Journal of Virology, 2006;80(12):6192-6194. SCI（共同第一作者）.11. Xun Sun, Li Hai, Yong Wu, Zhi-Rong Zhang. Targeted gene delivery to Hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). Journal of Drug Targeting. 2005;13(2):121-128. SCI.12. Xun Sun, You-Rong Duan, Oin He, Jiao Lu, Zhi-Rong Zhang. PELGE nanoparticles as new carriers for the delivery of plasmid DNA. Chem.Pharm.Bull. 2005; 53 (6):599-603. SCI.13. Xun Sun, Fang Wu, Wei Lu, Zhi-Rong Zhang. Sustained-release hydroxylcamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system. Pharmazie, 2004.59(10): 791-794. SCI.14. Xun Sun，Zhi-Rong Zhang. Optimizing the novel formulation of liposome- polycation-DNA complexes (LPD) by central composite design. Archives of Pharmacal Research 2004; 27(7): 797-805. SCI.15. Xun SUN，Hong-Wei ZHANG，Zhi-Rong ZHANG. Transfection efficiency of pORF lacZ plasmid lipopolyplexes to hepatocyte and hepatoma cells. World Journal of Gastroenterology. 2004，10(4):531-534.1. 国家基本医疗保险药品使用手册。北京：中国劳动社会保障出版社，2001.3 编委。2. 靶向治疗分子基础与靶向药物设计。北京：科学出版社。2005.10 编委
  